Safety and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzaetype b (DTPa-IPV/Hib) vaccine in healthy Vietnamese toddlers: An open-label, phase III study-Reference-Cited by-同舟云学术

Safety and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzaetype b (DTPa-IPV/Hib) vaccine in healthy Vietnamese toddlers: An open-label, phase III study

Published:2015-09-04 Issue:3 Volume:12 Page:655-657
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Anh Dang Duc,Van Der Meeren Olivier,Karkada Naveen,Assudani Deepak,Yu Ta-Wen,Han Htay Htay

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/21645515.2015.1084451

Reference15 articles.

1. Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzaetype b vaccine; Infanrix™ hexa

2. Systematic review of the effects of pertussis vaccines in children

3. Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine

4. Safety and Immunogenicity of Haemophilus influenzae‐Tetanus Toxoid Conjugate Vaccine Given Separately or in Combination with a Three‐Component Acellular Pertussis Vaccine Combined with Diphtheria and Tetanus Toxoids and Inactivated Poliovirus Vaccine for the First Four Doses

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and safety of concomitant administration of the chinese inactivated poliovirus vaccine with the diphtheria-tetanus-acellular pertussis (DTaP) vaccine in children: A multicenter, randomized, non-inferiority, controlled trial;Frontiers in Immunology;2022-07-26

2. Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China;Human Vaccines & Immunotherapeutics;2022-01-31

3. Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study;Human Vaccines & Immunotherapeutics;2020-02-12

4. Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines;Human Vaccines & Immunotherapeutics;2019-12-10

5. DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age;Expert Review of Vaccines;2019-11-02